Results 281 to 290 of about 192,697 (373)

Effects of passive immunization in patients with the acquired immunodeficiency syndrome-related complex and acquired immunodeficiency syndrome. [PDF]

A. Karpas, D. Gilgen, F. Hayhoe, F. Hill, J. Gray, L. Howard, M. Tenant-Flowers, M. Youle, N. Byron, V. Cullen   +9 more
core   +1 more source

Acquired Immunodeficiency Syndrome (AIDS)

Acta Médica del Centro, 2010
Carmen Garrido Arce, Elvys Pérez Bada, Carlos R. Cervera Cruz, Haydée González Pombal   +3 more
doaj  

Degradation and ecotoxicity of favipiravir and oseltamivir in the presence of microplastics during ozonation and catalytic ozonation of synthetic municipal wastewater effluents

Journal of Chemical Technology &Biotechnology, Volume 100, Issue 5, Page 955-966, May 2025.
Abstract Background Favipiravir (FAV) and oseltamivir (OSE) are antiviral agents developed against influenza and they were repurposed against SARS‐CoV‐2 during the COVID‐19 pandemic. This study evaluated the potential of ozonation and catalytic ozonation as tertiary treatment approaches for removing FAV and OSE from municipal wastewaters, both in the ...
Serdar Dogruel, Nasim Chavoshi, Nilay Bilgin‐Saritas, Alireza Khataee, Emel Topuz, Elif Pehlivanoglu   +5 more
wiley   +1 more source

Analysis of carbohydrates and glycoconjugates by matrix‐assisted laser desorption/ionization mass spectrometry: An update for 2021–2022

Mass Spectrometry Reviews, Volume 44, Issue 3, Page 213-453, May/June 2025.
Abstract The use of matrix‐assisted laser desorption/ionization (MALDI) mass spectrometry for the analysis of carbohydrates and glycoconjugates is a well‐established technique and this review is the 12th update of the original article published in 1999 and brings coverage of the literature to the end of 2022.
David J. Harvey
wiley   +1 more source

Avatrombopag for the Treatment of Immune Thrombocytopenia

European Journal of Haematology, Volume 114, Issue 5, Page 733-746, May 2025.
ABSTRACT Avatrombopag, a second‐generation thrombopoietin receptor agonist (TPO‐RA), represents a significant advancement in the treatment of chronic immune thrombocytopenic purpura (cITP) and a potential therapeutic option for other thrombocytopenic disorders.
Caterina Labanca, Ernesto Vigna, Enrica Antonia Martino, Antonella Bruzzese, Francesco Mendicino, Giulio Caridà, Eugenio Lucia, Virginia Olivito, Noemi Puccio, Antonino Neri, Fortunato Morabito, Massimo Gentile   +11 more
wiley   +1 more source

Neurologic involvement in the acquired immunodeficiency syndrome

Arquivos de Neuro-Psiquiatria, 1995
Sylvia Lemos Hinrichsen
doaj   +1 more source

Latest Progress on Tuberculosis and HIV Co‐Infection: A Closer Look at People of Different Ages

Advanced Therapeutics, Volume 8, Issue 4, April 2025.
Tackling the problem of tuberculosis (TB) and human immunodeficiency virus (HIV) co‐infection is a serious global health concern affecting people of all ages. This review presents the characteristics of both diseases, current treatment and diagnostic guidelines, associated problems, innovations in disease management, and overall effects on global ...
Anna Yusuf Aliyu, Oluwatoyin A. Adeleke
wiley   +1 more source

Effectiveness and Safety of Oral Azvudine for Elderly Hospitalized Patients With COVID‐19: A Multicenter, Retrospective, Real‐World Study

Advanced Science, Volume 12, Issue 13, April 3, 2025.
This multicenter, retrospective, real‐world study enrolls the largest hospitalized elderly cohort of COVID‐19 patients from nine hospitals in Henan Province to investigate the effectiveness and safety of Azvudine. The results show that compared controls, Azvudine treatment can reduce the rate of all‐cause death in elderly patients with COVID‐19, and ...
Ranran Sun, Haiyu Wang, Junyi Sun, Mengzhao Yang, Shixi Zhang, Xinjun Hu, Bo Yu, Zhan Song, Na Han, Hong Luo, Ming Cheng, Guangming Li, Guotao Li, Yiqiang Yuan, Lili Liang, Yanyang Zhang, Donghua Zhang, Silin Li, Quancheng Kan, Hongxia Liang, Zhigang Ren   +20 more
wiley   +1 more source

Amyloid precursor protein and presenilin‐1 knock‐in immunodeficient mice exhibit intraneuronal Aβ pathology, microgliosis, and extensive neuronal loss

Alzheimer's &Dementia, Volume 21, Issue 4, April 2025.
Abstract INTRODUCTION Transgenic mice overexpressing familial Alzheimer's disease (AD) mutations (FAD) show non‐physiological traits, and their immunocompetent backgrounds limit their use in AD immunotherapy research. Preclinical models that reflect human immune responses in AD are needed. METHODS Using CRISPR‐Cas9, we developed single (NA) and double (
Pravin Yeapuri, Jatin Machhi, Emma G. Foster, Rana Kadry, Shaurav Bhattarai, Yaman Lu, Susmita Sil, Roshan Sapkota, Shefali Srivastava, Mohit Kumar, Tsuneya Ikezu, Larisa Y. Poluektova, Howard E. Gendelman, Rodney Lee Mosley   +13 more
wiley   +1 more source